CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA

MONDAY, Oct. 20, 2025 (HealthDay News) -- Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have si